Private Equity

Private debt

Side Letter: Leveraging for liquidity

In today's edition, A $62bn pension is seeking leverage for liquidity; A sovereign wealth fund's PE allocation falls to a nine-year low – with a catch; Chinese PE activity rebounds.

4 min read · 26 August 2026

Blurred lines: How fund finance is reinventing the sub-line

As deploying capital gets harder, lenders and lawyers are turning to hybrid structures that blend sub-line mechanics with parallel vehicles and squeezing more leverage out of uncalled commitments.

5 min read · 17 August 2026

Side Letter: Growing pains

In today's edition, A 'democratisation' expert says GPs will only get one chance to deliver; Blackstone reckons evergreen 'tests' are helpful for the industry; New Mountain wants to deepen its Korea ties.

7 min read · 27 April 2026

Temasek and Hunter Point take minority stakes in Nuveen Private Capital

The investment into Churchill and Arcmont marks the Singapore’s sovereign wealth fund’s second such purchase in recent weeks.

3 min read · 03 September 2025

Investec’s sub line partnership with Ares gives GPs ‘confidence’

The securitisation partnership straddles a middle area between two-party and broadly syndicated arrangements.

4 min read · 14 July 2025

Arctos-backed Hayfin MBO represents 'trillion-dollar' opportunity

There are countless private markets firms that need a partner to help them grow in an era of scarce alpha and capital, says Arctos managing partner Ian Charles.

3 min read · 10 February 2025

PAI takes out €1bn-plus NAV loan against flagship fund assets

A portion of the NAV facility will be used to issue distributions back to LPs and is recallable if needed in the future, Private Equity International understands.

3 min read · 03 November 2023

How to future-proof debt

Forward-thinking managers can safeguard their investments by keeping abreast of emerging risk.

5 min read · 01 November 2023

The world of drug royalties financing

Asian healthcare specialist CBC Group believes specialised debt funds focused on pharma products can be complementary to equity investments.

3 min read · 01 November 2023

'It's hard to say if there’s more PE pain in future' – McKinsey

The lag in private equity reporting, differences in valuation methods and volatile macro environment will dictate the asset class’s performance in 2023, says McKinsey partner Brian Vickery.

3 min read · 21 March 2023

Showing 1 to 10 of 20 results
2